A Randomized, Double-Blind, Phase I/II Trial of Tumor Necrosis Factor and Interferon-Gamma for Treatment of AIDS-Related Complex (Protocol 025 from the AIDS Clinical Trials Group)-Reference-Cited by-同舟云学术

A Randomized, Double-Blind, Phase I/II Trial of Tumor Necrosis Factor and Interferon-Gamma for Treatment of AIDS-Related Complex (Protocol 025 from the AIDS Clinical Trials Group)

Published:1992-05 Issue:5 Volume:8 Page:581-587
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

AGOSTI JAN M.,COOMBS ROBERT W.,COLLIER ANN C.,PARADISE MARY A.,BENEDETTI JACQUELINE K.,JAFFE HOWARD S.,COREY LAWRENCE

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.1992.8.581

Reference29 articles.

1. Antiviral effects of recombinant tumour necrosis factor in vitro

2. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons

3. The Antiviral Activity of Recombinant Human Tumor Necrosis Factor-α

4. A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1.

5. Studies on the in vitro biological activities of recombinant bovine tumor necrosis factor (rBoTNF) alpha. I. Synergistic antiviral efficacy of rBoTNF alpha, recombinant bovine interferon gamma (rBoIFN gamma) and their combination

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis;Frontiers in Immunology;2014

2. Multiple levels of PKR inhibition during HIV-1 replication;Reviews in Medical Virology;2010-12-07

3. Leukocyte-Reduced Products;Blood Banking and Transfusion Medicine;2007

4. Low-Cost Anti-HIV Compounds: Potential Application for AIDS Therapy in Developing Countries;Current Pharmaceutical Design;2003-07-01

5. Interleukin‐18 Inhibits Human Immunodeficiency Virus Type 1 Production in Peripheral Blood Mononuclear Cells;The Journal of Infectious Diseases;2001-09